PASSAGE BIO, INC. (PASG) announced Loss for third quarter that decreased from the same period last year and beat the Street estimates.
The company's bottom line totaled -$7.75 million, or -$2.44 per share. This compares with -$19.34 million, or -$6.15 per share, last year.
Analysts on average had expected the company to earn -$2.97 per share. Analysts' estimates typically exclude special items.
PASSAGE BIO, INC. earnings at a glance (GAAP) :
-Earnings: -$7.75 Mln. vs. -$19.34 Mln. last year.-EPS: -$2.44 vs. -$6.15 last year.
For comments and feedback contact: editorial@rttnews.com
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.